S&P 500   2,925.73 (-1.78%)
DOW   25,201.91 (-2.19%)
QQQ   204.52 (-0.54%)
AAPL   270.43 (-1.13%)
FB   188.20 (-0.82%)
MSFT   159.88 (+1.07%)
CGC   18.15 (-1.57%)
NVDA   264.54 (+4.73%)
BABA   202.09 (-1.43%)
MU   52.36 (+3.52%)
AMD   45.36 (+3.07%)
T   34.91 (-2.30%)
ACB   1.37 (-5.54%)
F   6.86 (-1.58%)
NFLX   367.30 (-1.19%)
BAC   28.32 (-2.78%)
GILD   68.90 (-5.17%)
S&P 500   2,925.73 (-1.78%)
DOW   25,201.91 (-2.19%)
QQQ   204.52 (-0.54%)
AAPL   270.43 (-1.13%)
FB   188.20 (-0.82%)
MSFT   159.88 (+1.07%)
CGC   18.15 (-1.57%)
NVDA   264.54 (+4.73%)
BABA   202.09 (-1.43%)
MU   52.36 (+3.52%)
AMD   45.36 (+3.07%)
T   34.91 (-2.30%)
ACB   1.37 (-5.54%)
F   6.86 (-1.58%)
NFLX   367.30 (-1.19%)
BAC   28.32 (-2.78%)
GILD   68.90 (-5.17%)
S&P 500   2,925.73 (-1.78%)
DOW   25,201.91 (-2.19%)
QQQ   204.52 (-0.54%)
AAPL   270.43 (-1.13%)
FB   188.20 (-0.82%)
MSFT   159.88 (+1.07%)
CGC   18.15 (-1.57%)
NVDA   264.54 (+4.73%)
BABA   202.09 (-1.43%)
MU   52.36 (+3.52%)
AMD   45.36 (+3.07%)
T   34.91 (-2.30%)
ACB   1.37 (-5.54%)
F   6.86 (-1.58%)
NFLX   367.30 (-1.19%)
BAC   28.32 (-2.78%)
GILD   68.90 (-5.17%)
S&P 500   2,925.73 (-1.78%)
DOW   25,201.91 (-2.19%)
QQQ   204.52 (-0.54%)
AAPL   270.43 (-1.13%)
FB   188.20 (-0.82%)
MSFT   159.88 (+1.07%)
CGC   18.15 (-1.57%)
NVDA   264.54 (+4.73%)
BABA   202.09 (-1.43%)
MU   52.36 (+3.52%)
AMD   45.36 (+3.07%)
T   34.91 (-2.30%)
ACB   1.37 (-5.54%)
F   6.86 (-1.58%)
NFLX   367.30 (-1.19%)
BAC   28.32 (-2.78%)
GILD   68.90 (-5.17%)
Log in

Cara Therapeutics SEC Filings & 10K Form (NASDAQ:CARA)

$15.12
-0.23 (-1.50 %)
(As of 02/28/2020 11:40 AM ET)
Today's Range
$12.63
Now: $15.12
$15.39
50-Day Range
$15.35
MA: $16.68
$17.78
52-Week Range
$14.60
Now: $15.12
$27.55
Volume365,760 shs
Average Volume394,394 shs
Market Capitalization$605.25 million
P/E RatioN/A
Dividend YieldN/A
Beta2.26

SEC Filings

Cara Therapeutics (NASDAQ:CARA) SEC Filings

DateFilerForm TypeView
02/27/2020
3:10 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2020
1:33 PM
Cara Therapeutics (Subject)
RHO Ventures VI LP (Filed by)
Form SC 13G/A
02/05/2020
4:01 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
10:26 AM
BlackRock Inc. (Filed by)
Cara Therapeutics (Subject)
Form SC 13G/A
01/14/2020
7:00 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
5:06 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:05 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2019
5:06 PM
Cara Therapeutics (Issuer)
Makara Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/23/2019
7:00 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
5:05 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
1:18 PM
Cara Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
12/04/2019
6:52 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
6:50 PM
Cara Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
6:49 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
6:47 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
8:15 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
3:42 PM
Cara Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/20/2019
3:10 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
5:21 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
5:07 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:05 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2019
7:36 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:01 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
5:26 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2019
3:44 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
8:19 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
8:17 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
5:10 AM
Cara Therapeutics (Filer)
Form S-3ASR
09/05/2019
4:38 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
4:37 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
4:36 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
7:02 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
4:06 PM
Cara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
3:12 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
4:33 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
4:32 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
4:31 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
3:11 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
3:42 PM
Cara Therapeutics (Filer)
Form 424B5
07/24/2019
3:39 PM
Cara Therapeutics (Filer)
Form 424B5
07/24/2019
3:15 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
4:47 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
4:46 PM
Cara Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:10 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
3:04 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
2:59 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:47 PM
Cara Therapeutics (Issuer)
VOGELBAUM MARTIN (Reporting)
Form 4/A
06/06/2019
5:04 PM
Cara Therapeutics (Issuer)
VOGELBAUM MARTIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:03 PM
Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:01 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:00 PM
BAINS HARRISON M JR (Reporting)
Cara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
4:19 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
5:19 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
5:18 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
5:17 PM
Cara Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
5:16 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
6:17 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
4:01 PM
Cara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
3:10 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2019
3:18 PM
Cara Therapeutics (Filer)
Form DEFA14A
04/24/2019
3:15 PM
Cara Therapeutics (Filer)
Form DEF 14A
04/04/2019
11:15 PM
Cara Therapeutics (Filer)
Form EFFECT
03/21/2019
8:54 AM
Cara Therapeutics (Filer)
Form CT ORDER
03/15/2019
3:42 PM
Cara Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
3:34 PM
Cara Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/15/2019
3:31 PM
Cara Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/14/2019
4:13 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
4:01 PM
Cara Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2019
3:10 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
4:33 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
4:32 PM
Cara Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
4:32 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
4:31 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:53 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
4:49 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
4:29 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
12:50 PM
Cara Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G
02/14/2019
10:09 AM
Cara Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/05/2019
3:27 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
9:07 AM
BlackRock Inc. (Filed by)
Cara Therapeutics (Subject)
Form SC 13G/A
01/04/2019
3:22 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:56 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:56 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:55 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:54 PM
Cara Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2018
3:19 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2018
3:18 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2018
3:17 PM
Cara Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2018
3:15 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
3:18 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
3:16 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
3:22 PM
Cara Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
3:48 PM
Cara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2018
7:25 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
7:21 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2018
4:35 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2018
3:32 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2018
3:29 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2018
6:29 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2018
3:34 PM
Cara Therapeutics (Issuer)
Stauffer Joseph William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Featured Article: Most Volatile Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel